-
Landmark investment for life sciences in UK government Budget
europeanpharmaceuticalreview
March 13, 2020
The UK government has pledged funding of £22 billion per year into R&D by 2025 in its Budget, just days after a further £46 million was invested into coronavirus research.
-
Fujifilm Diosynth Breaks Ground in UK
contractpharma
March 13, 2020
Fujifilm Diosynth Biotechnologies (FDB), a cGMP contract development and manufacturing organization (CDMO) supporting its partners in the biopharmaceutical industry ...
-
Emerade 150 micrograms auto-injectors recalled in UK
europeanpharmaceuticalreview
March 09, 2020
The UK MHRA has announced that Emerade 150 micrograms solution for injection is being recalled due to an error in one component of the auto-injector.
-
3.5 million unlicensed erection pills seized in the UK in 2019
europeanpharmaceuticalreview
March 09, 2020
The UK MHRA has announced that the approximately 3.5 million unlicensed erection pills seized last year are worth more than £10 million.
-
Subcutaneous Remsima launched in UK
pharmatimes
March 06, 2020
Celltrion has announced the launch of its subcutaneous Remsima (infliximab) formulation, offering a new treatment option for UK physicians and their patients.
-
Import restrictions for cannabis-based medicines in UK updated
europeanpharmaceuticalreview
March 04, 2020
The UK government has changed the restrictions on importing cannabis-based medicine products into the country, allowing wholesalers to bring in larger quantities.
-
UK accounts for 12 percent of global cell and gene therapy clinical trials
europeanpharmaceuticalreview
January 19, 2020
New research has found that the cell and gene therapy clinical environment in the UK has encouraged commercial sponsorship from around the world.
-
Investment in UK cell and gene therapy manufacturing set to continue
europeanpharmaceuticalreview
December 09, 2019
An additional 6,000m2 of cell and gene therapy manufacturing space is expected to become available within the next 12 months, according to new data.
-
Enesi Gets Innovate UK Funding for Aseptic Mfg.
contractpharma
September 26, 2019
Enesi Pharma, a pharmaceutical company developing injectable solid dose drug-device vaccine products, has secured funding from Innovate UK under the Biomedical Catalyst 2019 Round 1: Early and Late Stage Awards Initiative.
-
UK to launch seven data hubs to garner insights for improved healthcare
europeanpharmaceuticalreview
September 16, 2019
The seven centres will aid disease research and clinical development, improving access to patient data for studies.